1 October 2018 in IEEE Transactions on Medical Imaging
We present a dynamic atlas composed of neuromelanin-enhanced magnetic resonance brain images of 40 healthy subjects. The performance of this atlas is evaluated on the fully automated segmentation of two paired neuromelanin-rich brainstem healthy structures: the substantia nigra pars compacta and the locus coeruleus. We show that our dynamic atlas requires in average 60% less images, and therefore 60% less computation time than a static multi-image atlas, while achieving similar segmentation performance. Then, we show that by applying our dynamic atlas, composed of healthy subjects, to the segmentation and neuromelanin quantification of a set of brain images of 39 Parkinson disease patients, we are able to find significant quantitative differences in the level of neuromelanin between healthy subjects and Parkinson disease patients, thus opening the door to the use of these structures as image biomarkers in future Computer Aided Diagnosis systems for the diagnosis of Parkinson disease.
15 April 2023 in npj Parkinson's Disease
Neuromelanin (NM) loss in substantia nigra pars compacta (SNc) and locus coeruleus (LC) reflects neuronal death in Parkinson’s disease (PD). Since genetically-determined PD shows varied clinical expressivity, we wanted to accurately quantify and locate brainstem NM and iron, to discover whether specific MRI patterns are linked to Leucine-rich repeat kinase 2 G2019S PD (LRRK2-PD) or idiopathic Parkinson’s disease (iPD). A 3D automated MRI atlas-based segmentation pipeline (3D-ABSP) for NM/iron-sensitive MRI images topographically characterized the SNc, LC, and red nucleus (RN) neuronal loss and calculated NM/iron contrast ratio (CR) and normalized volume (nVol). Left-side NM nVol was larger in all groups. PD had lower NM CR and nVol in ventral-caudal SNc, whereas iron increased in lateral, medial-rostral, and caudal SNc. The SNc NM CR reduction was associated with psychiatric symptoms. LC CR and nVol discriminated better among subgroups: LRRK2-PD had similar LC NM CR and nVol as that of controls, and larger LC NM nVol and RN iron CR than iPD. PD showed higher iron SNc nVol than controls, especially among LRRK2-PD. ROC analyses showed an AUC > 0.92 for most pairwise subgroup comparisons, with SNc NM being the best discriminator between HC and PD. NM measures maintained their discriminator power considering the subgroup of PD patients with less than 5 years of disease duration. The SNc iron CR and nVol increase was associated with longer disease duration in PD patients. The 3D-ABSP sensitively identified NM and iron MRI patterns strongly correlated with phenotypic PD features.
20 June 2017 in European Journal of Social Psychology
4 November 2025 in medRxiv
Background: Firstly, to determine whether iron-sensitive MRI measures mediate neuromelanin (NM) loss within the substantia nigra pars compacta (SNc) and its subregion, nigrosome-1 (N1) in idiopathic Parkinson’s disease (iPD) and GBA -associated Parkinson’s disease (GBA-PD) versus healthy controls (HC). Secondly, to assess the diagnostic value of NM-and iron MRI metrics, including their lateralisation. Methods: Eighty-six participants (HC=30, iPD = 30, GBA-PD = 26) underwent midbrain quantitative NM-MRI and susceptibility-weighted imaging (SWI). Contrast ratio (CR), normalised volume (nVol) and left-right asymmetry indices (AI) of SNc and N1 calculated. Receiver-operating analyses assessed group discrimination and onset-side prediction. Bidirectional causal mediation (5,000 bootstraps, FDR-corrected) tested Iron→NM→group and NM→Iron→group pathways. Moderation models examined the effect of GBA-mutation severity. Results: iPD and GBA-PD showed marked NM loss and increased iron in SNc/N1, being more prominent in GBA-PD. N1 NM metrics provided the strongest discrimination (HC vs GBA-PD AUC=0.93, HC vs iPD AUC=0.83), followed by iron measures (AUC=0.78-0.89). N1 NM asymmetry yielded moderate lateralisation accuracy (AUC=0.76). Cross-sectional mediation analyses identified significant Iron→NM→group effects across SNc and N1 (q<0.01), supporting mechanistic hypotheses of iron-driven NM depletion in PD. In GBA-PD, NM-iron coupling in N1 was influenced by mutation severity, suggesting a genotype-specific disruption of NM-iron homeostasis. Conclusions: Multi-contrast MRI centered on N1 reveals an iron-driven NM imbalance that distinguishes PD from controls and it is modulated by GBA mutation severity, supporting the applicability of N1-focused NM-iron imaging as a biomarker for PD diagnosis. Note: This manuscript has been submitted to Journal of Neurology, Neurosurgery & Psychiatry for consideration.
17 June 2025 in Journal of Neonatal Nursing
DRDana Gabriela Riaño-Albornoz
Dana Gabriela Riaño-Albornoz
SVSara Salomé Vélez-Cárdenas
Sara Salomé Vélez-Cárdenas
KTKarol Gabriela Tamayo-Tibaduiza
Karol Gabriela Tamayo-Tibaduiza
+1
28 October 2026 in npj Parkinson's Disease